CA3133556A1 - Structures medicales composites a rigidification dynamique - Google Patents
Structures medicales composites a rigidification dynamique Download PDFInfo
- Publication number
- CA3133556A1 CA3133556A1 CA3133556A CA3133556A CA3133556A1 CA 3133556 A1 CA3133556 A1 CA 3133556A1 CA 3133556 A CA3133556 A CA 3133556A CA 3133556 A CA3133556 A CA 3133556A CA 3133556 A1 CA3133556 A1 CA 3133556A1
- Authority
- CA
- Canada
- Prior art keywords
- rigidizing
- cannula
- layer
- vacuum
- rigidizing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims description 19
- 239000012530 fluid Substances 0.000 claims abstract description 48
- 238000004891 communication Methods 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 230
- 230000002787 reinforcement Effects 0.000 claims description 109
- 230000000747 cardiac effect Effects 0.000 claims description 91
- 230000004913 activation Effects 0.000 claims description 75
- 210000003484 anatomy Anatomy 0.000 claims description 57
- 239000000463 material Substances 0.000 claims description 55
- 239000011159 matrix material Substances 0.000 claims description 52
- 230000007704 transition Effects 0.000 claims description 40
- 210000004115 mitral valve Anatomy 0.000 claims description 34
- 230000003213 activating effect Effects 0.000 claims description 30
- 210000002216 heart Anatomy 0.000 claims description 30
- 230000007246 mechanism Effects 0.000 claims description 26
- 229920001296 polysiloxane Polymers 0.000 claims description 26
- 239000012528 membrane Substances 0.000 claims description 24
- 210000004379 membrane Anatomy 0.000 claims description 24
- 230000008439 repair process Effects 0.000 claims description 23
- 229910052751 metal Inorganic materials 0.000 claims description 21
- 239000002184 metal Substances 0.000 claims description 21
- 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 claims description 20
- 210000000013 bile duct Anatomy 0.000 claims description 17
- 210000005246 left atrium Anatomy 0.000 claims description 17
- -1 polyetherimicle Substances 0.000 claims description 17
- 210000000277 pancreatic duct Anatomy 0.000 claims description 12
- 241001631457 Cannula Species 0.000 claims description 11
- 210000001367 artery Anatomy 0.000 claims description 10
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 10
- 210000003462 vein Anatomy 0.000 claims description 10
- 229920003023 plastic Polymers 0.000 claims description 9
- 239000004033 plastic Substances 0.000 claims description 9
- 210000005245 right atrium Anatomy 0.000 claims description 9
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 8
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 8
- 229920002530 polyetherether ketone Polymers 0.000 claims description 8
- 230000007423 decrease Effects 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 7
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 7
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 7
- 210000002376 aorta thoracic Anatomy 0.000 claims description 6
- 210000001105 femoral artery Anatomy 0.000 claims description 6
- 210000003191 femoral vein Anatomy 0.000 claims description 6
- 210000005240 left ventricle Anatomy 0.000 claims description 6
- 229920001684 low density polyethylene Polymers 0.000 claims description 6
- 239000004702 low-density polyethylene Substances 0.000 claims description 6
- 230000002612 cardiopulmonary effect Effects 0.000 claims description 5
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 210000005003 heart tissue Anatomy 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 210000005241 right ventricle Anatomy 0.000 claims description 4
- 210000000591 tricuspid valve Anatomy 0.000 claims description 4
- 238000002586 coronary angiography Methods 0.000 claims description 3
- 229920001903 high density polyethylene Polymers 0.000 claims description 3
- 239000004700 high-density polyethylene Substances 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 794
- 238000005452 bending Methods 0.000 description 55
- 230000033001 locomotion Effects 0.000 description 42
- 230000006835 compression Effects 0.000 description 28
- 238000007906 compression Methods 0.000 description 28
- 239000000835 fiber Substances 0.000 description 28
- 238000000576 coating method Methods 0.000 description 27
- 239000011248 coating agent Substances 0.000 description 26
- 239000010408 film Substances 0.000 description 23
- 210000001035 gastrointestinal tract Anatomy 0.000 description 23
- 238000011282 treatment Methods 0.000 description 22
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 17
- 238000001125 extrusion Methods 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 229920001971 elastomer Polymers 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000853 adhesive Substances 0.000 description 13
- 230000001070 adhesive effect Effects 0.000 description 13
- 229910001220 stainless steel Inorganic materials 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 238000002052 colonoscopy Methods 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 229920000139 polyethylene terephthalate Polymers 0.000 description 11
- 239000005020 polyethylene terephthalate Substances 0.000 description 11
- 239000010935 stainless steel Substances 0.000 description 11
- 238000013461 design Methods 0.000 description 10
- 238000003384 imaging method Methods 0.000 description 10
- 210000005166 vasculature Anatomy 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 210000001072 colon Anatomy 0.000 description 9
- 239000000806 elastomer Substances 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 210000003157 atrial septum Anatomy 0.000 description 7
- 230000009977 dual effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 7
- 238000013022 venting Methods 0.000 description 7
- 238000012800 visualization Methods 0.000 description 7
- 238000012323 Endoscopic submucosal dissection Methods 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 6
- 210000001765 aortic valve Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000002271 resection Methods 0.000 description 6
- 238000005096 rolling process Methods 0.000 description 6
- 239000005060 rubber Substances 0.000 description 6
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 5
- 239000012636 effector Substances 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 210000001198 duodenum Anatomy 0.000 description 4
- 238000012326 endoscopic mucosal resection Methods 0.000 description 4
- 238000001839 endoscopy Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 210000003709 heart valve Anatomy 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 238000005461 lubrication Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 4
- 229920000271 Kevlar® Polymers 0.000 description 3
- 239000004697 Polyetherimide Substances 0.000 description 3
- 229920000508 Vectran Polymers 0.000 description 3
- 239000004979 Vectran Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 210000001715 carotid artery Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002674 endoscopic surgery Methods 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 238000002594 fluoroscopy Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000004761 kevlar Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229920001601 polyetherimide Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000002432 robotic surgery Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 229920002799 BoPET Polymers 0.000 description 2
- 229920000049 Carbon (fiber) Polymers 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005041 Mylar™ Substances 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 229920001494 Technora Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 239000004917 carbon fiber Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 238000002181 esophagogastroduodenoscopy Methods 0.000 description 2
- 239000002783 friction material Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000013152 interventional procedure Methods 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000004950 technora Substances 0.000 description 2
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 101150051159 ARTN gene Proteins 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- FAIFRACTBXWXGY-JTTXIWGLSA-N COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]1(OC)C=C[C@@]35C[C@@H]1[C@](C)(O)CCc1ccccc1 Chemical compound COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]1(OC)C=C[C@@]35C[C@@H]1[C@](C)(O)CCc1ccccc1 FAIFRACTBXWXGY-JTTXIWGLSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 101150044878 US18 gene Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 210000003767 ileocecal valve Anatomy 0.000 description 1
- 210000003111 iliac vein Anatomy 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000006623 intrinsic pathway Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000012907 on board imaging Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 210000002321 radial artery Anatomy 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000002579 sigmoidoscopy Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007464 sphincterotomy Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001042 thoracic artery Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Un système robotique, comprenant : une canule interne allongée rigidifiante comprenant plusieurs couches, dont une première couche vessie; une canule allongée externe rigidifiante concentrique à la canule allongée interne, dans laquelle la canule allongée externe comprend une deuxième couche vessie; et une cassette à l'extrémité proximale de la canule allongée externe, dans laquelle la cassette est configurée pour s'engager avec une unité d'entraînement pour avancer et rétracter alternativement la canule allongée externe par rapport à la canule allongée interne, et dans laquelle la cassette comprend un lumen de pression en communication fluide avec la deuxième couche vessie, dans laquelle la cassette est configurée pour appliquer le vide ou la pression à travers le lumen de pression pour rigidifier la canule allongée extérieure.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835101P | 2019-04-17 | 2019-04-17 | |
| US62/835,101 | 2019-04-17 | ||
| PCT/US2020/013937 WO2020214221A1 (fr) | 2019-04-17 | 2020-01-16 | Structures médicales composites à rigidification dynamique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3133556A1 true CA3133556A1 (fr) | 2020-10-22 |
Family
ID=78610741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3133556A Pending CA3133556A1 (fr) | 2019-04-17 | 2020-01-16 | Structures medicales composites a rigidification dynamique |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA3133556A1 (fr) |
-
2020
- 2020-01-16 CA CA3133556A patent/CA3133556A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11478608B2 (en) | Dynamically rigidizing composite medical structures | |
| US20220323166A1 (en) | Dynamically rigidizing composite medical structures | |
| US20230210351A1 (en) | Rigidizing devices | |
| US20240024640A1 (en) | Dynamically rigidizing guiderail and methods of use | |
| US11793392B2 (en) | External working channels | |
| US20070260225A1 (en) | Steerable sheath actuator | |
| WO2024030975A2 (fr) | Procédés et appareils de rigidification dynamique | |
| AU2023217708A1 (en) | Dynamically rigidizing composite medical structures | |
| CA3133556A1 (fr) | Structures medicales composites a rigidification dynamique | |
| US20240350768A1 (en) | Rigidizing overtube | |
| US20230338709A1 (en) | Steerable member and system and methods of making and using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220922 |
|
| EEER | Examination request |
Effective date: 20220922 |
|
| EEER | Examination request |
Effective date: 20220922 |
|
| EEER | Examination request |
Effective date: 20220922 |
|
| EEER | Examination request |
Effective date: 20220922 |
|
| EEER | Examination request |
Effective date: 20220922 |